1. Home
  2. WGRX vs NVNO Comparison

WGRX vs NVNO Comparison

Compare WGRX & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WGRX
  • NVNO
  • Stock Information
  • Founded
  • WGRX 2022
  • NVNO 1987
  • Country
  • WGRX United States
  • NVNO United States
  • Employees
  • WGRX N/A
  • NVNO N/A
  • Industry
  • WGRX Other Pharmaceuticals
  • NVNO Medical/Dental Instruments
  • Sector
  • WGRX Health Care
  • NVNO Health Care
  • Exchange
  • WGRX Nasdaq
  • NVNO Nasdaq
  • Market Cap
  • WGRX 66.1M
  • NVNO 71.0M
  • IPO Year
  • WGRX 2025
  • NVNO N/A
  • Fundamental
  • Price
  • WGRX $0.86
  • NVNO $4.29
  • Analyst Decision
  • WGRX
  • NVNO
  • Analyst Count
  • WGRX 0
  • NVNO 0
  • Target Price
  • WGRX N/A
  • NVNO N/A
  • AVG Volume (30 Days)
  • WGRX 230.7K
  • NVNO 105.3K
  • Earning Date
  • WGRX 08-11-2025
  • NVNO 07-30-2025
  • Dividend Yield
  • WGRX N/A
  • NVNO N/A
  • EPS Growth
  • WGRX N/A
  • NVNO N/A
  • EPS
  • WGRX N/A
  • NVNO N/A
  • Revenue
  • WGRX $28,992,274.00
  • NVNO N/A
  • Revenue This Year
  • WGRX N/A
  • NVNO N/A
  • Revenue Next Year
  • WGRX N/A
  • NVNO N/A
  • P/E Ratio
  • WGRX N/A
  • NVNO N/A
  • Revenue Growth
  • WGRX N/A
  • NVNO N/A
  • 52 Week Low
  • WGRX $0.82
  • NVNO $2.03
  • 52 Week High
  • WGRX $7.04
  • NVNO $6.48
  • Technical
  • Relative Strength Index (RSI)
  • WGRX N/A
  • NVNO 49.70
  • Support Level
  • WGRX N/A
  • NVNO $3.89
  • Resistance Level
  • WGRX N/A
  • NVNO $4.06
  • Average True Range (ATR)
  • WGRX 0.00
  • NVNO 0.22
  • MACD
  • WGRX 0.00
  • NVNO -0.05
  • Stochastic Oscillator
  • WGRX 0.00
  • NVNO 14.06

About WGRX Wellgistics Health Inc. Common Stock

Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. It is focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: